Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life. Planas R, Martin R, Sospedra M Patient Relat Outcome Meas. 2014; 5:25-33. Epub 2014 Apr 04. PMID: 24741337. Abstract CommentRecommendBookmarkWatch